microRNA-21靶向调控Wnt2基因对肝癌细胞HepG2增殖与迁移的影响

王泽鑫; 关利君; 李建明; 王志超; 薛梦若; 秦孝军

doi:10.3969/j.issn.1001-5256.2020.04.019

microRNA-21靶向调控Wnt2基因对肝癌细胞HepG2增殖与迁移的影响

DOI: 10.3969/j.issn.1001-5256.2020.04.019

内蒙古医科大学附属医院介入放射科

基金项目:

内蒙古自治区自然科学基金(2017MS0890)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1154
- HTML全文浏览量: 23
- PDF下载量: 205
- 被引次数: 0
出版历程
- 收稿日期: 2019-11-15
- 出版日期: 2020-04-20

Effect of targeted regulation of the Wnt2 gene by microRNA( microRNA-21) on the proliferation and migration of HepG2 hepatoma cells

Department of Interventional Radiology,The Affiliated Hospital of Inner Mongolia Medical University

Research funding:

摘要

摘要: 目的探讨分析microRNA-21（miR-21）靶向调控Wnt2基因对肝癌细胞HepG2增殖与迁移的影响。方法采用实时荧光定量PCR法检测肝癌细胞HepG2及正常肝细胞株LO2 miR-21的表达情况。对HepG2细胞转染miR-21抑制剂,分析转染后抑制剂组与对照组miR-21的表达情况、细胞增殖、迁移及凋亡情况,检测两组细胞Wnt2蛋白表达水平,并采用双荧光素酶报告基因实验验证miR-21与Wnt2基因的关系。计量资料两组间比较采用t检验。结果 HepG2细胞miR-21相对表达水平明显高于LO2细胞（1. 978±0. 035 vs 1. 586±0. 022,t=16. 424,P <0. 05）。转染miR-21抑制剂后,抑制剂组miR-21相对表达水平较对照组显著降低（0. 857±0. 017 vs 1. 684±0. 039,t=33. 669,P <0. 05）。转染miR-21抑制剂24、48、72 h后,抑制剂组HepG2细胞增殖能力均较对照组显著降低（P值均<0. 05）;抑制剂组穿过Tranwell小室的细胞数显著低于对照组（83. 72±...
- 微RNAs /
- Wnt2蛋白质 /
- 癌,肝细胞 /
- 细胞增殖 /
- 细胞运动
Abstract: Objective To investigate the effect of targeted regulation of the Wnt2 gene by microRNA( miR-21) on the proliferation and migration of HepG2 hepatoma cells. Methods Quantitative real-time PCR was used to measure the mRNA expression of miR-21 in HepG2 hepatoma cells and normal liver cell line LO2. HepG2 cells were transfected with miR-21 inhibitor,and then the expression of miR-21 and cell proliferation,migration,and apoptosis were analyzed for the inhibitor group and the control group. The protein expression of Wnt2 was measured for the two groups,and dual-luciferase reporter assay was used to verify the association between miR-21 and the Wnt2 gene. The t-test was used for comparison of continuous data between groups. Results The relative expression of miR-21 in HepG2 cells was significantly higher than that in LO2 cells( 1. 978 ± 0. 035 vs 1. 586 ± 0. 022,t = 16. 424,P < 0. 05). After the transfection of miR-21 inhibitor,the inhibitor group had significantly lower expression of miR-21 than the control group( 0. 857 ± 0. 017 vs 1. 684 ± 0. 039,t= 33. 669,P < 0. 05). Compared with the control group after the transfection of miR-21 inhibitor,the inhibitor group had a significant reduction in the proliferation ability of HepG2 cells( P < 0. 05),a significantly lower number of cells passing through the Transwell chamber( 83. 72 ± 15. 06 vs 147. 85 ± 20. 64,t = 4. 347,P < 0. 05),and a significantly higher cell apoptosis rate( 25. 67% ± 3. 95% vs 10. 27%± 2. 14%,t = 5. 937,P < 0. 05). The inhibitor group had significantly lower relative expression of Wnt2 in HepG2 cells than the control group( 0. 862 ± 0. 127 vs 1. 306 ± 0. 218,t = 3. 048,P < 0. 05). TargetScan software showed that miR-21 inhibitor significantly inhibited the luciferase activity of the cells transfected with wild-type Wnt2-3'UTR plasmid( 0. 972 ± 0. 102 vs 0. 612 ± 0. 092,t = 4. 219,P <0. 05),while there was no effect on the luciferase activity of the cells transfected with mutant Wnt2-3' UTR plasmid( 0. 982 ± 0. 093 vs0. 911 ± 0. 128,t = 0. 972,P > 0. 05). Conclusion Inhibition of miR-21 expression can effectively inhibit the proliferation and migration of HepG2 cells,promote the apoptosis of HepG2 cells,and inhibit the over-activation of the Wnt signaling pathway,and therefore,it may become one of the potential target genes for liver cancer treatment.
- microRNAs /
- Wnt2 protein /
- carcinoma,hepatocellular /
- cell proliferation /
- cell movement

HTML全文

参考文献(24)

[1] LI YH,ZHANG H,XIONG SX. The effects of miR-125a in inhibiting the invasion,proliferation and migration of hepatocellular carcinoma cells-HepG2 by down-regulating the expression of VEGF[J]. Hebei Med J,2019,41(16):2405-2410.(in Chinese)李贻弘，张宏，熊首先．miR-125a下调血管因子VEGF抑制肝癌细胞的侵袭、增殖、迁移及周期S期[J]．河北医药，2019,41(16):2405-2410.

[2] DENG XJ,GONG SX,YANG SH,et al. MicroRNA-539 inhibiting the occurrence and development of hepatocellular carcinoma by targeting E2F transcription factor 3[J]. Acta Anatomica Sinica,2018,49(4):469-474.(in Chinese)邓学军，龚邵新，杨胜辉，等．MicroRNA-539靶向调控E2F转录因子3抑制肝癌的发生与发展[J]．解剖学报，2018,49(4):469-474.

[3] LILIAN AM,SIMONE CS,DANIELE S,et al. Comparison of the effects of monastrol and oxomonastrol on human hepatoma cell line HepG2/C3A[J]. Anticancer Res,2017,37(3):1197-1204.

[4] WENBIN W,XIAO Y,AMAN X,et al. Human cancer cells suppress behaviors of endothelial progenitor cells through miR-21targeting IL6R[J]. Microvascular Res,2018,120:21-28.

[5] SUN N,ZHANG G,LIU Y. Long non-coding RNA XIST sponges miR-34a to promotes colon cancer progression via Wnt/β-catenin signaling pathway[J]. Gene,2018,30(665):141-148.

[6] LI X,LUO XL. Research progress of miRNAs regulating tumor microenvironment[J]. Curr Immunol,2019,39(3):245-248.(in Chinese)李欣，罗小玲．miRNA调控肿瘤微环境的研究进展[J]．现代免疫学，2019,39(3):245-248.

[7] NATHAN WW,YUHAO C,SHUAI C,et al. OncomiR:An online resource for exploring pan-cancer microRNA dysregulation[J]. Bioinformatics,2017,34(4):713-715.

[8] ZHAO YL,WANG HB,MAO TZ,et al. Research progress on the relationship between microRNA and tumor[J]. Oncol Prog,2019,17(12):1365-1367,1384.(in Chinese)赵银龙，王洪冰，毛铁铸，等．microRNA与肿瘤关系的研究进展[J]．癌症进展，2019,17(12):1365-1367,1384.

[9] CAO YG,XIA GB,GUO J,et al. Effect of miR-939-5p on the migration and proliferation of hepatocellular carcinoma by regulating the expression of USP22 gene[J]. Int J Surg,2019,46(2):119-123.(in Chinese)曹玉刚，夏国兵，郭浚，等．miR-939-5p调控USP22基因表达对肝癌迁移和增殖的影响[J]．国际外科学杂志，2019,46(2):119-123.

[10] SONG Y,XU Y,WANG Z,et al. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer[J]. Int J Cancer,2012,131(5):1042-1051.

[11] YAO LH,WANG GR,CAI Y,et al. The expressions and diagnostic values of miR-18a and miR-21 in esophageal cancer[J]. Chin J Oncol,2019,41(2):107-111.(in Chinese)姚丽华，汪光蓉，蔡燕，等．miR-18a和miR-21在食管癌中的表达及其对食管癌的诊断价值[J]．中华肿瘤杂志，2019,41(2):107-111.

[12] XU DW,MA PJ,GAO GJ,et al. The effect of long non-coding RNA MEG3 on cell proliferation,migration and invasion of glioma cell line U251 via targeting miR-21[J]. J Chin Oncol,2019,25(6):524-530.(in Chinese)徐大伟，马鹏举，高国军，等．长链非编码RNA MEG3靶向miR-21对胶质瘤U251细胞增殖、侵袭和迁移的影响[J]．肿瘤学杂志，2019,25(6):524-530.

[13] XIN R,LI D,XU HY,et al. Influence of miRNA-21 in radiosensitivity of breast cancer cells and its mechanism[J]. J Jilin Univ(Med Edit),2019,45(4):772-778.(in Chinese)信瑞，李冬，徐慧英，等．miRNA-21对乳腺癌细胞放射敏感性的影响及其机制[J]．吉林大学学报(医学版)，2019,45(4):772-778.

[14] XIE RT,CONG XL,ZHONG XM,et al. MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma[J]. Oncol Lett,2018,15(4):4571-4577.

[15] HUANG X. Advances of microRNAs in translational medicine and immunotherapy of renal tumors[J]. J Int Transl Med,2016,4(2):103-108.

[16] LIU F,LIANG GD,WANG Y,et al. Expression of miR-21 in hepatocellular carcinoma and its correlation with prognosis[J]. Chin J Gerontol,2016,36(1):115-116.(in Chinese)刘峰，梁国栋，王岩，等．肝细胞肝癌组织中miR-21表达水平及与预后的相关性[J]．中国老年学杂志，2016,36(1):115-116.

[17] PU CW,HUANG H,WANG ZD,et al. Extracellular vesicleassociated miR-21 and miR-144 are markedly elevated in serum of patients with hepatocellular carcinoma[J]. Front Physiol,2018,9:930.

[18] WANG WY,ZHANG HF,TANG M,et al. Expression of miR-21 in liver cancer and its relationship with PTEN[J]. Chin J Gen Surg,2017,26(3):395-400.(in Chinese)王文耀，张鸿飞，唐淼，等．miR-21在肝癌中的表达及其与PTEN的关系[J]．中国普通外科杂志，2017,26(3):395-400.

[19] ZHANG Q,LI XT,CHEN Y,et al. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells[J]. Cancer Chemoth Pharm,2018,81:969-977.

[20] FAN LK,MA C. Recombinant human DKK1 protein in oral squamous cell carcinoma stem cell migration and invasion role[J]. Clin J Med Offic,2018,46(2):187-190.(in Chinese)范龙坤，马超．人重组蛋白DKK1对口腔鳞癌干细胞迁移及侵袭能力作用[J]．临床军医杂志，2018,46(2):187-190.

[21] LUSTIG B,BEHRENS J. The Wnt signaling pathway and its role in tumor development[J]. J Cancer Res Clin Oncol,2003,129(4):199-221.

[22] LI H,ZHOU DJ. Wnt2/β-catenin signaling pathway and its role in tumors[J]. Guangdong Med J,2015,36(2):320-323.(in Chinese)李华，周德俊．Wnt2/β-catenin信号通路及其在肿瘤中的作用[J]．广东医学，2015,36(2):320-323.

[23] SUN F,WANG JZ,LUO JJ,et al. MiR-21 and miR-130b targeted artificially designed circRNAs inhibit epithelial-mesenchymal transition in liver cancer cells[J]. Chin Med Dev,2018,33(1):52-54.(in Chinese)孙芳，王金枝，罗吉君，等．miR-21和miR-130b靶向性人工设计circRNA抑制肝癌细胞上皮间质转化[J]．中国医疗设备，2018,33(1):52-54.

[24] LIU KM,GUO L,XI T. Mechanism of ursolic acid inducing apoptosis of liver cancer HepG2 cells by inhibiting miR-21 expression[J]. J Chin Pharm Univ,2015,6(6):108-113.(in Chinese)刘昆梅，郭乐，奚涛．乌索酸通过抑制miR-21表达诱导肝癌HepG2细胞凋亡的机制[J]．中国药科大学学报，2015,6(6):108-113.

施引文献

资源附件(0)

访问统计